|
| 36976017 | Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIV Acquisition. | | 2023 |
| 37738240 | Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus. | PLoS Pathog | 2023 |
| 37075126 | An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans. | | 2023 |
| 37436899 | HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide. | Cell Rep | 2023 |
| 37427791 | RNA helicase DDX6 and scaffold protein GW182 in P-bodies promote biogenesis of stress granules. | | 2023 |
| 37104089 | Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants. | | 2023 |
| 36848985 | Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node. | | 2023 |
| 37098956 | Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization. | | 2023 |
| 35324257 | Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. | Science | 2022 |
| 35526534 | Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2. | | 2022 |
| 35841885 | Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability. | Structure | 2022 |
| 35709309 | Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4. | PLoS Pathogens | 2022 |
| 36356572 | Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses. | Immunity | 2022 |
| 35568025 | LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. | Cell Rep | 2022 |
| 36344847 | Cryo-EM structures of prefusion SIV envelope trimer. | Nat Struct Mol Biol | 2022 |
| 35489332 | Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite. | Structure | 2022 |
| 35609088 | Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron. | PLoS ONE | 2022 |
| 35413243 | Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site. | Structure | 2022 |
| 36119018 | Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens. | Frontiers in Immunology | 2022 |
| 35783486 | Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial. | eClinicalMedicine | 2022 |
| 36582240 | Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings. | Front Immunol | 2022 |
| 33972947 | LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. | bioRxiv | 2022 |
| 35319830 | Development of Neutralization Breadth against Diverse HIV-1 by Increasing Ab-Ag Interface on V2. | Advanced Science | 2022 |
| 34986348 | Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys. | Cell Rep | 2022 |
| 35283191 | Antigenic analysis of the HIV-1 envelope trimer implies small differences between structural states 1 and 2. | Journal of Biological Chemistry | 2022 |
| 35115707 | A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination. | Nature Medicine | 2022 |
| 35081298 | SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination. | N Engl J Med | 2022 |
| 34931200 | Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization. | medRxiv | 2021 |
| 34242577 | In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. | Cell | 2021 |
| 33688659 | Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants. | bioRxiv | 2021 |
| 33688652 | Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates. | | 2021 |
| 33948590 | A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice. | bioRxiv | 2021 |
| 34210892 | Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. | Science | 2021 |
| 33831133 | High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19. | PLoS Pathog | 2021 |
| 33453152 | Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth. | Immunity | 2021 |
| 34098567 | Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. | Nature | 2021 |
| 33826898 | Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base. | Cell Reports | 2021 |
| 33655255 | High-Throughput, Single-Copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19. | bioRxiv | 2021 |
| 33655252 | Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants. | bioRxiv | 2021 |
| 33442694 | The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates. | bioRxiv | 2021 |
| 33442681 | Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses. | bioRxiv | 2021 |
| 34135892 | Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses. | Front Immunol | 2021 |
| 34315825 | Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. | Science Translational Medicine | 2021 |
| 34244481 | Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINs. | Nature Communications | 2021 |
| 33649208 | Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody. | Proc Natl Acad Sci U S A | 2021 |
| 33494381 | Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses. | Vaccines (Basel) | 2021 |
| 34408080 | Blocking αβ integrin delays viral rebound in SHIV-infected macaques treated with anti-HIV broadly neutralizing antibodies. | Science Translational Medicine | 2021 |
| 34461095 | SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity. | J Biol Chem | 2021 |
| 34981053 | Neutralization and Stability of SARS-CoV-2 Omicron Variant. | | 2021 |
| 34731616 | Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies. | Cell Rep | 2021 |